Schedule 13D ownership disclosure

OMEGA THERAPEUTICS INC

Security class unavailable · CUSIP: 68217N105

Event date: 2023-02-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
2.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-050932
Form type
SC 13D/A
Filer
Flagship Ventures Fund V, L.P.
CIK
CIK 1627639
Filed
Feb 27, 2023
Reporting period
Feb 22, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub